Work

Construction and Preliminary Characterization of a Physically Assembled Non-Crosslinked mPEG-PCL/Hyaluronic Acid Formulation as an Injectable Soft-Tissue Filler

Year: 2026
Type: article
Abstract: Injectable soft-tissue fillers require a balance among injectability, shape support, tissue compatibility, and predictable post-injection behavior. We evaluated CB301, a physically compounded, non-crosslinked methoxy poly(ethylene glycol)-block-poly(ε-caprolactone) (mPEG-PCL)/hyaluronic acid (HA) formulation for soft-tissue filling. Physicochemical characterization showed nanoscale mPEG-PCL-associated structures and sterilization-associated changes in colloidal organization, while gel permeation chromatography (GPC) indicated only minor changes in the molecular-weight distribution of recovered mPEG-PCL. CB301 exhibited elastic-dominant rheology and substantially higher complex viscosity than concentration-matched mPEG-PCL and HA single-component controls. A CB301 extract showed no obvious cytotoxicity in L929 cells. Subcutaneous histology showed an early mild local response that decreased over time, and greater fascia-to-epidermis tissue thickness at CB301 sites than at saline-control sites. After administration of CB301 containing Cy5.5-labeled mPEG-PCL, localized mPEG-PCL-associated fluorescence remained detectable through 35 d, with decreasing relative intensity and progressive spatial broadening. These findings support further investigation of CB301 as a selected non-crosslinked mPEG-PCL/HA injectable soft-tissue filler formulation.
Language: English
Subfield: Biomaterials
Open Access status: gold
Estimated APC paid: $1,820
OpenAlex ID: W7237335697
FWCI:
Cites:
Cited by:
Related to: